DNLRX
Price
$62.90
Change
+$0.48 (+0.77%)
Updated
Jul 3 closing price
Net Assets
473.18M
VMCPX
Price
$383.04
Change
+$2.26 (+0.59%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

DNLRX vs VMCPX

Header iconDNLRX vs VMCPX Comparison
Open Charts DNLRX vs VMCPXBanner chart's image
BNY Mellon Active MidCap I
Price$62.90
Change+$0.48 (+0.77%)
VolumeN/A
Net Assets473.18M
Vanguard Mid Cap Index InstitutionalPlus
Price$383.04
Change+$2.26 (+0.59%)
VolumeN/A
Net Assets185.28B
DNLRX vs VMCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNLRX vs. VMCPX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLRX is a Buy and VMCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 185B vs. DNLRX (473M). VMCPX pays higher dividends than DNLRX: VMCPX (1.54) vs DNLRX (0.99). DNLRX was incepted earlier than VMCPX: DNLRX (23 years) vs VMCPX (15 years). DNLRX (0.92) is less costly to investors than VMCPX (0.03). DNLRX is a more actively managed with annual turnover of: 51.78 vs. VMCPX (16.00). DNLRX has a lower initial minimum investment than VMCPX: DNLRX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 16.95 vs. DNLRX (7.36). VMCPX return over 5 years is better than : 72.78 vs. DNLRX (35.22).
DNLRXVMCPXDNLRX / VMCPX
Total Expense Ratio0.750.032,500%
Annual Report Gross Expense Ratio0.920.033,067%
Fund Existence23 years15 years-
Gain YTD4.8566.99669%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets473M185B0%
Annual Yield % from dividends0.991.5464%
Returns for 1 year7.3616.9543%
Returns for 3 years28.4742.2967%
Returns for 5 years35.2272.7848%
Returns for 10 years10.32126.278%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUS8.920.10
+1.13%
NuSkin Enterprises
FATE1.12N/A
N/A
Fate Therapeutics
RIOT12.17-0.03
-0.25%
Riot Platforms
UMC7.83-0.03
-0.38%
United Microelectronic Corp
BGLC6.43-0.39
-5.72%
Bionexus Gene Lab Corp